- Home
- Publications
- Publication Search
- Publication Details
Title
How Does the Ketogenic Diet Work? Four Potential Mechanisms
Authors
Keywords
-
Journal
JOURNAL OF CHILD NEUROLOGY
Volume 28, Issue 8, Pages 1027-1033
Publisher
SAGE Publications
Online
2013-05-14
DOI
10.1177/0883073813487598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Behavioral, cognitive, and safety profile of 2-deoxy-2-glucose (2DG) in adult rats
- (2012) Jeffrey C. Ockuly et al. EPILEPSY RESEARCH
- Multiple Roles for Mammalian Target of Rapamycin Signaling in Both Glutamatergic and GABAergic Synaptic Transmission
- (2012) M. C. Weston et al. JOURNAL OF NEUROSCIENCE
- BAD-Dependent Regulation of Fuel Metabolism and KATP Channel Activity Confers Resistance to Epileptic Seizures
- (2012) Alfredo Giménez-Cassina et al. NEURON
- Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats
- (2012) X. Huang et al. NEUROSCIENCE
- Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy
- (2012) Anna Sliwa et al. NEUROSCIENCE LETTERS
- The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway
- (2012) Delia M. Talos et al. PLoS One
- The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
- (2012) Adam L. Hartman et al. PLoS One
- The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
- (2012) Carl E. Stafstrom et al. Frontiers in Pharmacology
- Neuron-restrictive silencer factor is not required for the antiepileptic effect of the ketogenic diet
- (2011) Xiao-Ling Hu et al. EPILEPSIA
- The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway
- (2011) Sharon S. McDaniel et al. EPILEPSIA
- Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice
- (2011) C. Nicole Sunnen et al. EPILEPSIA
- Modulation of oxidative stress and mitochondrial function by the ketogenic diet
- (2011) Julie Milder et al. EPILEPSY RESEARCH
- Preictal and Ictal Neurovascular and Metabolic Coupling Surrounding a Seizure Focus
- (2011) M. Zhao et al. JOURNAL OF NEUROSCIENCE
- Single KATP Channel Opening in Response to Action Potential Firing in Mouse Dentate Granule Neurons
- (2011) G. R. Tanner et al. JOURNAL OF NEUROSCIENCE
- Rapamycin Suppresses Mossy Fiber Sprouting But Not Seizure Frequency in a Mouse Model of Temporal Lobe Epilepsy
- (2011) P. S. Buckmaster et al. JOURNAL OF NEUROSCIENCE
- A pulse rapamycin therapy for infantile spasms and associated cognitive decline
- (2011) Emmanuel Raffo et al. NEUROBIOLOGY OF DISEASE
- Reversal of Diabetic Nephropathy by a Ketogenic Diet
- (2011) Michal M. Poplawski et al. PLoS One
- The Cell Biology of Synaptic Plasticity
- (2011) V. M. Ho et al. SCIENCE
- Anticonvulsant and proconvulsant actions of 2-deoxy-d-glucose
- (2010) Maciej Gasior et al. EPILEPSIA
- Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex
- (2010) L.-H. Zeng et al. HUMAN MOLECULAR GENETICS
- Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
- (2010) Xiaoxing Huang et al. NEUROBIOLOGY OF DISEASE
- Metabolic Control of Vesicular Glutamate Transport and Release
- (2010) Narinobu Juge et al. NEURON
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models
- (2009) Carl E. Stafstrom et al. ANNALS OF NEUROLOGY
- The tuberous sclerosis complex
- (2009) Ksenia A. Orlova et al. Annals of the New York Academy of Sciences
- Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia
- (2009) M. C. Ljungberg et al. Disease Models & Mechanisms
- Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy
- (2009) David A. Muzykewicz et al. EPILEPSIA
- Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet
- (2009) BThomas N Seyfried et al. Journal of Cancer Research and Therapeutics
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy
- (2009) L.-H. Zeng et al. JOURNAL OF NEUROSCIENCE
- BAD: undertaker by night, candyman by day
- (2009) N N Danial ONCOGENE
- Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine
- (2009) Renske van Delft et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Chronic ingestion of 2-deoxy-d-glucose induces cardiac vacuolization and increases mortality in rats
- (2009) Robin K. Minor et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- Seizure suppression via glycolysis inhibition with 2-deoxy-D-glucose (2DG)
- (2008) Carl E. Stafstrom et al. EPILEPSIA
- Efficacy of the ketogenic diet in the 6-Hz seizure test
- (2008) Adam L. Hartman et al. EPILEPSIA
- A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy
- (2008) Elizabeth G. Neal et al. EPILEPSIA
- Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group
- (2008) Eric H. Kossoff et al. EPILEPSIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started